» Articles » PMID: 39319021

Smokers' Characteristics Associated with Successful Smoking Cessation Undergoing Pharmacotherapy in Slovenia

Overview
Journal Zdr Varst
Publisher Sciendo
Specialty Public Health
Date 2024 Sep 25
PMID 39319021
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Tobacco use is a major global health problem, contributing to premature death and disability. In Slovenia, the prevalence of smoking is higher than the EU average, emphasizing the need for effective tobacco control measures. The aim of this study was to identify the characteristics of patients most likely to benefit from pharmacotherapy for smoking cessation.

Methods: We performed cross-sectional analysis of factors associated with successful smoking cessation using pharmacotherapy for Slovenian smokers. A total of 176 (24.6%) smokers with an average age of 50 years agreed to receive pharmacotherapy for their smoking cessation attempt and were enrolled in the study. Participants were followed up at 4-week intervals during treatment and for 24 weeks after completion of pharmacotherapy.

Results: Attempts to quit smoking with prescription medications were successful in 24.4% of those willing to try. Female smokers, older persons, those with more children, with a lower self-perception of health, a higher number of cigarettes per day and a higher nicotine dependence were more likely to attempt to quit smoking. However, the strongest predictors of smoking cessation success were lower nicotine dependence, which was tested using the Fagerström test for nicotine dependence, and higher adherence to pharmacotherapy.

Conclusion: Nicotine dependence and adherence to pharmacotherapy are the strongest predictors of a successful smoking cessation attempt. Identification of potential responders, prescription of pharmacotherapy and follow-up are applicable in the primary healthcare setting.

References
1.
Kim Y . Predictors for successful smoking cessation in Korean adults. Asian Nurs Res (Korean Soc Nurs Sci). 2014; 8(1):1-7. DOI: 10.1016/j.anr.2013.09.004. View

2.
Giulietti F, Filipponi A, Rosettani G, Giordano P, Iacoacci C, Spannella F . Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice. High Blood Press Cardiovasc Prev. 2020; 27(5):349-362. PMC: 7309212. DOI: 10.1007/s40292-020-00396-9. View

3.
Kale D, Gilbert H, Sutton S . Are predictors of making a quit attempt the same as predictors of 3-month abstinence from smoking? Findings from a sample of smokers recruited for a study of computer-tailored smoking cessation advice in primary care. Addiction. 2015; 110(10):1653-64. DOI: 10.1111/add.12972. View

4.
. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

5.
Hock E, Franklin M, Baxter S, Clowes M, Chilcott J, Gillespie D . Covariates of success in quitting smoking: a systematic review of studies from 2008 to 2021 conducted to inform the statistical analyses of quitting outcomes of a hospital-based tobacco dependence treatment service in the United Kingdom. NIHR Open Res. 2023; 3:28. PMC: 10596416. DOI: 10.3310/nihropenres.13427.2. View